UPDATE: Auriga Raises Price Target on Allscripts-Misys to $25
According to Auriga, Allscripts-Misys (NASDAQ: MDRX) price target is raised to $25.
Auriga said that it is reiterating its BUY rating on Allscripts (MDRX) following an in-line quarter and guide. “Our new target, up from $23, is based on our newly introduced FY13 estimates.”
Allscripts-Misys closed yesterday at $21.47.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.